Table 2.
Clinical and demographic data of 274 patients with suspected cutaneous leishmaniasis (CL) attending the NMLCP clinic in Kabul. Cases were patients testing positive on microscopy or PCR or both.
| Cases (N = 257) | Non-cases (N = 17) | ||
|---|---|---|---|
| Gender | Female | 135 (52·5%) | 8 (47·1%) |
| Male | 122 (47·5%) | 9 (52·9%) | |
| X2 = 0·19; p = 0·6619 | |||
| Age (years) | 5–14 | 99 (38.5%) | 7 (41·2%) |
| 15–39 | 102 (39·7%) | 6 (35·3%) | |
| 40–59 | 41 (15·9%) | 3 (17·6%) | |
| ≥60 | 15 (5·8%) | 1 (5·9%) | |
| Median | 20 years | 24 years | |
| IQR | 11–35 years | 13–35 years | |
| Z = 0·18; p = 0·8570 | |||
| Number of lesions | Single | 182 (70·8%) | 15 (88·2%) |
| Multiple | 75 (29·2%) | 2 (11·8%) | |
| X2 = 2·39; p = 0·1217 | |||
| Number of patients with a lesion at a specific locationa | Facial/head/neck | 45 (17·5%) | 3 (17·6%) |
| X2 = 0·00; p = 0·9885 | |||
| Limbs/trunk | 82 (31·9%) | 5 (29·4%) | |
| X2 = 0·04; p = 0·8305 | |||
| Hands | 151 (58·7%) | 10 (58·8%) | |
| X2 = 0; p = 0·9955 | |||
| Feet | 11 (4·3%) | 1 (5·9%) | |
| X2 = 0·10; p = 0·7546 | |||
| Lesion typeb | Nodule | 188 (73·1%) | 6 (35·3%) |
| Ulcer | 65 (25·3%) | 11 (64·7%) | |
| Plaque | 3 (1·2%) | 0 (0%) | |
| Nodule + Ulcer | 1 (0·4%) | 0 (0%) | |
| X2 = 12·42; p = 0·0061¥ | |||
| Lesion duration (months)b | <2 | 24 (9·3%) | 1 (5·9%) |
| 2 | 105 (40·8%) | 4 (23·5%) | |
| 3 | 69 (26·8%) | 6 (35·3%) | |
| 4 | 51 (19·8%) | 6 (35·3%) | |
| 5 | 4 (1·5%) | 0 (0%) | |
| ≥6 | 2 (0·8%) | 0 (0%) | |
| Unknown | 2 (0·8%) | 0 (0%) | |
| Median | 2 months | 3 months | |
| IQR | 2–3 months | 2–4 months | |
| Z = −1·577; p = 0·1149 |
IQR: Interquartile range.
a
Multiple locations are possible.
b
Main lesion (lesion sampled).
¥
Statistically significant.